PaceMate Announces Strategic Investment from Lead Edge Capital


SARASOTA, Fla.–(BUSINESS WIRE)–PaceMate®, a market leading cardiac data management platform, announced today a strategic growth investment from Lead Edge Capital, a technology-focused investment fund that has invested in leading companies such as Duo Security, Toast, Spotify, Wise, Alibaba Group, and Grafana.

PaceMate offers comprehensive and flexible cardiac data management software and 24.7.365 clinical service solutions. PaceMate is the market leader in electronic health record interoperability, harmonizing disparate cardiac and EHR data to create workflow solutions in a single, cloud-native environment.

“Lead Edge Capital’s investment propels our strategic vision and growth trajectory, allowing us to rapidly scale our presence, expand our product portfolio, and deliver flexible solutions to more healthcare institutions. As the pioneer in cardiac remote monitoring, we are elevating cardiac digital healthcare with data-rich and interoperable environments, integrating essential patient data in real-time to enhance efficiency and patient outcomes,” said Tripp Higgins, CEO and Co-Founder at PaceMate.

The investment follows significant momentum and a record year for PaceMate, which has grown revenues in excess of 100% while adding several top cardiac practices and health systems as customers.

“PaceMate delivers a powerful set of solutions focused on improving patient care and outcomes within the cardiac disease segment. Over the past several years, the company has worked tirelessly to deliver superior technology, service, and a level of care which has been unparalleled within the market. We are thrilled to partner with Tripp and the team on PaceMate’s next phase of growth,” said Brian Neider, Partner at Lead Edge Capital.

Raymond James & Associates, Inc. served as financial advisor, and Foley & Lardner, LLP served as legal counsel to PaceMate. TripleTree, LLC served as financial advisor, and Goodwin Procter, LLP served as legal counsel to Lead Edge Capital in connection with this transaction.

About PaceMate

Recognized as a Top 100 Healthcare Technology Company by Healthcare Technology Report, PaceMate offers the most comprehensive remote cardiac monitoring solution in the industry. PaceMateLIVE is the only clinical dashboard with user-friendly integrations for all implantable cardiac devices, ambulatory monitors, consumer ECGs, and heart failure products. PaceMate’s Auto-Triage™ prioritizes patients based on clinician-customized standards – not device alerts – resulting in substantial reduction in alert burden. With the most live connections through EHR-partnered integrations, PaceMate offers a true, vetted, and validated industry-leading solution for interoperability: ensuring real-time bi-directional data transfer for more accurate reporting, streamlined workflows, and automated billing. PaceMate’s software-only, concierge on-demand, and full-service offerings deliver a flexible, customized solution to your cardiac practice.

About Lead Edge Capital

Lead Edge Capital is a growth stage investment fund with $5 billion of capital raised since inception, and portfolio companies across the internet, software, consumer, and tech-enabled services sectors. The firm has invested in market leading businesses including Alibaba Group, Asana, Bazaarvoice, Benchling, Duo Security, Grafana, Revenue Analytics, Spotify, Toast, and Wise. Lead Edge Capital offers its entrepreneurs flexible capital and extensive domain expertise via its robust Limited Partner Network, a global advisory group of leading executives, entrepreneurs, and dealmakers who have built and run some of the world’s most successful companies. Lead Edge Capital leverages its LPs to connect companies with the customers, partners, talent, and advisors needed to accelerate success. Lead Edge Capital was founded in 2009 and has offices in New York City and Santa Barbara, California.